A rise in tech shares lifted Japan's Nikkei and Taiwan's TAIEX to all-time highs on Tuesday, though other markets in the ...

Shares in Warren Buffett’s conglomerate are rising after Berkshire Hathaway reported a 33% jump in third-quarter operating ...

Richard Bernstein, Richard Bernstein Advisors CEO and CIO, joins 'Closing Bell Overtime' with reaction to Palantir's Q3 ...

The Fiserv crash calls attention to other popular stocks with sell ratings and helps investors manage risk. Click here to see ...

Nuveen Preferred & Income Opportunities Fund (JPC) offers a 9.78% yield, outperforming preferred stock indices and peer funds ...

Shares of the Tylenol maker jumped by nearly one-fifth in premarket trading on the news that Kimberly-Clark (KMB) would ...

Broadcom's stock began rising in early September after the company reported better-than-expected Q3 results. The company's ...

Now, it’s worth noting Stock Advisor’s total average return is 1,072% — a market-crushing outperformance compared to 194 % ...

To really cap off a well-rounded portfolio, you should add non-U.S. companies. That's where the Vanguard Total International ...

The pharma company's newer immunology drugs, Skyrizi and Rinvoq, have delivered robust sales growth that's proving to be the ...

London stocks dipped on Tuesday despite a sharp drop in the pound following finance minister Rachel Reeves' comments, as equities around the world tumbled in a broader risk-off move.

The Nifty Pharma Index has risen 51% over the last two years, outperforming the Nifty 50 Index, which gained 34%. Select ...